Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,385,025
New position
Shares Held
103,592
first reported quarter
Ownership
0.606%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in RNA
reported options exposure · as of Mar 31, 2026CallValue
$812,896
CallShares
60,800
PutValue
$534,800
PutShares
40,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $196,103,961 across 70 Biotechnology names. RNA ranks #24 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in RNA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,385,025 | 103,592 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $534,800 | 40,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $812,896 | 60,800 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||